Showing results (541-550 of 863) with videos related to
Sort By:
Pageof 87
Med (New York, N.Y.)|May 23, 2024
Decision model for durable clinical benefit from front- or late-line immunotherapy alone or with chemotherapy in non-small cell lung cancerJie Zhao, Lu Wang, Anda Zhou, et al.Med (New York, N.Y.)|April 13, 2024
Melanoma neoantigen vaccines: Are we getting more personal now?Sofiya Latifyan, John B HaanenMed (New York, N.Y.)|April 25, 2024
Blocking cGAS-STING pathway promotes post-stroke functional recovery in an extended treatment window via facilitating remyelinationMunire Maimaiti, Chenhui Li, Mingxing Cheng, et al.Med (New York, N.Y.)|April 26, 2024
Enhanced interactions among gut mycobiomes with the deterioration of glycemic controlJia-Lin He, Ya-Wen Zhao, Jia-Lu Yang, et al.Med (New York, N.Y.)|January 27, 2026
EBUS-guided transbronchial mediastinal cryobiopsy for diagnosing non-metastatic lymphadenopathy: A randomized controlled trialMingming Deng, Ziwen Zheng, Xiaofei Zhang, et al.Med (New York, N.Y.)|January 28, 2026
Specificities of pediatric listeriosis beyond the neonatal period: A national prospective studyCaroline Charlier, Sofieya Vijayaratnam, Capucine Jeanton-Seybel, et al.Med (New York, N.Y.)|February 14, 2026
Advancing mediastinal sampling in non-metastatic lymphadenopathyReto Engeli, Carolin Steinack, Juergen Hetzel, et al.Med (New York, N.Y.)|January 11, 2025
Belzutifan for renal cell carcinoma: Balancing regulatory approval with societal and patient impactJad Chahoud, Pavlos MsaouelMed (New York, N.Y.)|December 31, 2024
Randomized double-blind study on safety and tolerability of TP-102 phage cocktail in patients with infected and non-infected diabetic foot ulcersRan Nir-Paz, Hadil Onallah, Michal Dekel, et al.Med (New York, N.Y.)|December 14, 2024
Perioperative immunotherapy in urothelial carcinoma: AMBASSADOR charts the path forwardKriti Mittal, Monika JoshiPageof 87